Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography–tandem mass spectrometry and its application in a pharmacokinetic study
Authors:
- Ning LiNLNing Li
- Ting QinTQTing Qin
- Yi ZhangYZYi Zhang
- Famei LiFLFamei Li
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 878 (7-8) , 689-694
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoringJournal of Chromatography B, 2003
- Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatographyJournal of Chromatography B, 2002
- Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Use of vancomycin silica stationary phase in packed capillary electrochromatographyJournal of Chromatography A, 2001
- Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Simultaneous measurement of venlafaxine and its major metabolite, oxydesmethylvenlafaxine, in human plasma by high-performance liquid chromatography with coulometric detection and utilisation of solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- AntidepressantsDrugs, 1989
- Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivativeBiochemical Pharmacology, 1986
- DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activityEuropean Journal of Pharmacology, 1985